V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220021867 | 220008341 | 1.59 | 28.3 | Curative (C) | 2017-06-03 | 2017-06-03 | Arsenic trioxide + Tretinoin | N | null | 220031681 | ARSENIC TRIOXIDE + TRETINOIN |
| 220021868 | 220008353 | 1.69 | 67.5 | Curative (C) | 2017-12-09 | 2018-01-23 | Arsenic Triox + Tretinoin Ind W5-8 | 2 | null | 220031700 | ARSENIC TRIOXIDE + TRETINOIN |
| 220021869 | 220008359 | 1.92 | 66.8 | Curative (C) | 2014-01-10 | 2014-01-24 | Oxaliplatin + Modified de Gramont | 02 | N | 220031735 | FLUDARABINE + MELPHALAN |
| 220021870 | 220008389 | 1.76 | 15.8 | null | 2019-03-23 | 2019-05-03 | Carboplatin + Paclitaxel (weekly) | 2 | N | 220031813 | CARBOPLATIN + PACLITAXEL |
| 220021871 | 220008393 | 1.73 | 96.8 | Curative (C) | 2015-04-03 | 2015-07-03 | METHOTREXATE | Y | N | 220031821 | METHOTREXATE |
| 220021872 | 220008421 | 1.88 | null | Curative (C) | 2017-06-13 | 2017-06-15 | ALEMTUZUMAB + BUSULFAN + FLUDARABINE | N | N | 220031947 | GEMTUZUMAB OZOGAMICIN |
| 220021873 | 220008426 | 1.69 | 75.6 | Curative (C) | 2018-03-17 | 2018-03-20 | Docetaxel | N | N | 220031977 | FBC |
| 220021874 | 220008436 | null | 41.65 | Curative (C) | 2018-03-15 | 2018-03-15 | Clofarabine + Cytarabine | null | null | 220032025 | FLUDARABINE + MELPHALAN |
| 220021875 | 220008444 | 1.78 | 119 | Adjuvant (A) | 2017-09-12 | 2017-10-28 | FLUDARABINE + MELPHALAN | N | N | 220032039 | GEMCARBO |
| 220021876 | 220014583 | 1.65 | 75.6 | Curative (C) | 2018-09-08 | 2018-09-20 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032072 | GEMCARBO |
| 220021877 | 220008467 | null | 50.8 | Curative (C) | null | 2016-11-17 | Paclitaxel (2 or 3 weekly) | 02 | null | 220032105 | PACLITAXEL |
| 220021878 | 220014589 | 1.72 | 94.2 | Curative (C) | 2014-07-21 | 2014-07-26 | Clofarabine + Cytarabine | N | N | 220032108 | PONATINIB |
| 220021879 | 220008494 | 1.73 | 94.9 | Curative (C) | 2015-03-13 | 2015-03-19 | IDARUBICIN | 2 | N | 220032156 | IDARUBICIN |
| 220021880 | 220008502 | 1.83 | 75.4 | Adjuvant (A) | 2016-03-01 | 2016-03-28 | Paclitaxel 7 day | N | N | 220032158 | PACLITAXEL |
| 220021881 | 220008506 | null | 66.4 | Curative (C) | 2014-03-08 | 2014-04-02 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 220032159 | PONATINIB |
| 220021882 | 220014612 | null | 28.15 | Palliative (P) | 2015-06-07 | 2015-07-09 | BORTEZOMIB + THALIDOMIDE | 02 | N | 220032227 | METHOTREXATE + PEGASPARGASE |
| 220021884 | 220008586 | 0 | 88 | Palliative (P) | 2016-12-23 | 2017-04-03 | CAMELLIA Trial | N | N | 220032405 | IPILIMUMAB |
| 220021885 | 220008591 | 1.6 | 73 | Disease modification (D) | 2013-10-24 | 2014-09-28 | FIGARO TRIAL | Y | N | 220032418 | LIPOSOMAL CYTARABINE |
| 220021886 | 220014644 | 1.69 | 84.5 | Curative (C) | null | 2018-02-16 | Venetoclax | N | N | 220032464 | CARBOPLATIN |
| 220021887 | 220008606 | null | null | Curative (C) | 2016-03-24 | 2016-03-24 | AFATINIB | N | N | 220032477 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE + MELPHALAN |
| 220021888 | 220008623 | 1.7 | 72.5 | Curative (C) | 2016-09-09 | 2016-09-21 | MACE | N | N | 220032532 | CYTARABINE IT + METHOTREXATE |
| 220021889 | 220008770 | 1.68 | 90 | Curative (C) | 2017-01-10 | 2017-04-30 | BUSULFAN + FLUDARABINE + METHOTREXATE | N | Y | 220032973 | MACE |
| 220021891 | 220014743 | 1.51 | 66.1 | Palliative (P) | 2017-03-30 | 2017-04-10 | THALIDOMIDE | 01 | N | 220033250 | AXITINIB |
| 220021892 | 220018065 | 1.81 | 83 | Disease modification (D) | 2017-05-22 | 2017-05-29 | TRASTUZUMAB | Y | N | 220033397 | VIOLA TRIAL |
| 220021893 | 220008900 | 1.64 | null | Curative (C) | 2016-11-16 | 2016-11-16 | Cytarabine+Methotrexate Intrathecal | N | null | 220033508 | CYTARABINE IT + METHOTREXATE |
| 220021894 | 220008912 | 1.84 | 9.7 | Disease modification (D) | 2017-02-06 | 2017-02-19 | Capecitabine + Oxaliplatin 21day | N | N | 220033551 | CLOFARABINE |
| 220021895 | 220008960 | 1.64 | null | Curative (C) | 2016-10-19 | 2017-12-02 | FLA | N | N | 220033807 | ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE |
| 220021896 | 220008969 | 1.73 | 81.1 | Curative (C) | 2018-12-04 | 2018-12-04 | MidAC | 2 | N | 220033808 | LENALIDOMIDE |
| 220021897 | 220009012 | 0 | 55.4 | Disease modification (D) | 2016-12-26 | 2017-02-03 | CETUXIMAB + IRINOTECAN + MDG | N | N | 220033965 | FIGARO TRIAL |
| 220021898 | 220009023 | 1.75 | 82 | Curative (C) | 2015-02-11 | 2015-03-10 | SPIRIT 2 TRIAL | N | N | 220033988 | VINCRISTINE |
| 220021899 | 220014823 | 1.61 | 120 | Disease modification (D) | 2017-05-30 | 2017-05-30 | Alemtuzumab+Busulfan+CyclophosphMUD | N | N | 220034022 | UKALL2011 |
| 220021900 | 220009050 | 1.77 | 79 | Curative (C) | 2016-02-28 | 2016-03-02 | Trifluridine + Tipiracil | 02 | N | 220034079 | ARSENIC TRIOXIDE + ATRA |
| 220021901 | 220009053 | 1.52 | 80 | Palliative (P) | 2015-02-27 | 2015-04-20 | MACE | N | N | 220034081 | WT1 TRIAL |
| 220021902 | 220009062 | null | null | Disease modification (D) | null | 2017-05-26 | FLUDARABINE | null | null | 220034115 | CYTARABINE IT + METHOTREXATE |
| 220021903 | 220009069 | 1.73 | 46.7 | Curative (C) | 2015-04-04 | 2015-04-04 | Bevacizumab 7.5mg/kg | 01 | null | 220034117 | CARBOPLATIN |
| 220021904 | 220009105 | 1.65 | 52.2 | Disease modification (D) | 2018-06-23 | 2018-06-23 | INTERFERON | N | N | 220034277 | FIGARO TRIAL |
| 220021905 | 220022112 | null | 79.3 | null | null | 2016-12-10 | CYTARABINE + MITOXANTRONE | 01 | N | 220034302 | BUSULPHAN + CYCLO |
| 220021906 | 220009115 | 1.68 | 45 | Curative (C) | 2014-11-13 | 2014-11-21 | PEMBROLIZUMAB | null | null | 220034334 | BUSULPHAN + FLUDARABINE |
| 220021907 | 220009135 | 1.64 | 65 | Curative (C) | 2017-09-29 | 2017-10-06 | DAUNORUBICIN | N | N | 220034423 | CYTARABINE + IDARUBICIN |
| 220021908 | 220009137 | 1.8 | null | Disease modification (D) | 2018-12-22 | 2018-12-23 | Alemtuzumab+Busulfan+CyclophosphMUD | N | null | 220034424 | BUSULFAN + FLUDARABINE |
| 220021909 | 220009162 | 1.55 | 89 | Curative (C) | 2015-03-12 | 2015-04-24 | FIGARO TRIAL | N | N | 220034495 | FIGARO TRIAL |
| 220021911 | 220014964 | null | null | null | 2012-07-02 | 2013-09-15 | Cytarabine+Methotrexate Intrathecal | N | N | 220035347 | MACE |
| 220021912 | 220009374 | null | null | Curative (C) | 2016-05-27 | 2016-06-02 | BUSULFAN + CYCLO | N | N | 220035412 | CYTARABINE IT + METHOTREXATE |
| 220021914 | 220009410 | 1.6 | 82 | Curative (C) | 2014-12-09 | 2015-10-05 | Capecitabine | N | N | 220035549 | ETOPOSIDE |
| 220021915 | 220009433 | null | null | Disease modification (D) | 2016-02-02 | 2016-02-08 | Cyclophosphamide High Dose | null | null | 220035672 | CYTARABINE IT + METHOTREXATE |
| 220021917 | 220009476 | 1.65 | null | Curative (C) | 2017-11-14 | 2017-11-21 | MITOXANTRONE + TRETINOIN | N | null | 220035947 | BENDAMUSTINE + RITUXIMAB |
| 220021918 | 220009500 | 1.84 | null | Curative (C) | 2015-11-29 | 2016-04-11 | BORTEZOMIB + THALIDOMIDE | null | N | 220036062 | SORAFENIB |
| 220021919 | 220009511 | 1.76 | null | Disease modification (D) | 2016-04-24 | 2016-04-24 | MELPHALAN | N | N | 220036121 | LIPOSOMAL CYTARABINE |
| 220021920 | 220009580 | 1.64 | 73 | Disease modification (D) | 2018-05-02 | 2018-08-14 | Everolimus 10mg | 02 | N | 220036432 | ATG + BUSULFAN + CYCLOPHOSPHAMIDE |
| 220021921 | 220009596 | 1.59 | 50.3 | Palliative (P) | 2016-06-17 | 2017-07-10 | BUSULFAN + CYCLO | 2 | N | 220036524 | CISPLATIN + ETOPOSIDE |